These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 28547750)
21. Patients with psoriasis are more likely to be treated for latent tuberculosis infection prior to biologics than patients with inflammatory bowel disease. Bassukas ID; Kosmidou M; Gaitanis G; Tsiouri G; Tsianos E Acta Derm Venereol; 2011 Jun; 91(4):444-6. PubMed ID: 21547342 [TBL] [Abstract][Full Text] [Related]
22. Intermediate to long-term follow-up results of INH chemoprophylaxis prior to anti-TNF-alpha therapy in a high-risk area for tuberculosis. Kurt OK; Kurt B; Talay F; Tug T; Soy M; Bes C; Hayran M Wien Klin Wochenschr; 2013 Oct; 125(19-20):616-20. PubMed ID: 24061693 [TBL] [Abstract][Full Text] [Related]
23. [The relevance of diagnostic criteria for latent tuberculosis before initiation of TNF-alpha inhibitors in psoriasis patients]. Goujon C; Gormand F; Gunera-Saad N; Dahel K; Vial T; Nicolas JF Ann Dermatol Venereol; 2010; 137(6-7):437-43. PubMed ID: 20620572 [TBL] [Abstract][Full Text] [Related]
24. Baseline abnormal liver function tests are more important than age in the development of isoniazid-induced hepatoxicity for patients receiving preventive therapy for latent tuberculosis infection. Gray EL; Goldberg HF Intern Med J; 2016 Mar; 46(3):281-7. PubMed ID: 26648478 [TBL] [Abstract][Full Text] [Related]
25. Clinical experience of QuantiFERON(®) -TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan. Chiu HY; Hsueh PR; Tsai TF Br J Dermatol; 2011 Mar; 164(3):553-9. PubMed ID: 21083541 [TBL] [Abstract][Full Text] [Related]
26. Diagnosis and treatment of latent tuberculosis infection in patients undergoing treatment with immunobiologic agents: a four-year experience in an endemic area. Lopes DMA; Pinheiro VGF; Monteiro HSA J Bras Pneumol; 2019; 45(6):e20180225. PubMed ID: 31618298 [TBL] [Abstract][Full Text] [Related]
27. LTBI screening in rheumatoid arthritis patients prior to anti-TNF treatment in an endemic area. Bonfiglioli KR; Ribeiro AC; Moraes JC; Saad CG; Souza FH; Calich AL; Bonfa E; Laurindo IM Int J Tuberc Lung Dis; 2014 Aug; 18(8):905-11. PubMed ID: 25199003 [TBL] [Abstract][Full Text] [Related]
28. Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom. Nisar MK; Rafiq A; Östör AJ Clin Rheumatol; 2015 Dec; 34(12):2141-5. PubMed ID: 26497501 [TBL] [Abstract][Full Text] [Related]
29. Isoniazid prophylaxis in liver transplant recipient with latent tuberculosis: Is it harmful for transplanted liver? Ghayumi SMA; Shamsaeefar A; Motazedian N; Mashhadiagha A; Sayadi M; Nikeghbalian S; Malekhosseini SA Transpl Infect Dis; 2022 Aug; 24(4):e13849. PubMed ID: 35579604 [TBL] [Abstract][Full Text] [Related]
30. Isoniazid therapy for latent tuberculosis in psoriasis patients receiving biological agents: is it safe and efficacious? Sánchez-Moya AI; Dauden E Int J Dermatol; 2014 Mar; 53(3):e211-2. PubMed ID: 23786208 [No Abstract] [Full Text] [Related]
31. Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs. Goletti D; Petrone L; Ippolito G; Niccoli L; Nannini C; Cantini F Expert Rev Anti Infect Ther; 2018 Jun; 16(6):501-512. PubMed ID: 29848120 [TBL] [Abstract][Full Text] [Related]
32. Outcomes of Treatment for Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy. Ramos GP; Stroh G; Al-Bawardy B; Faubion WA; Papadakis KA; Escalante P Inflamm Bowel Dis; 2018 Sep; 24(10):2272-2277. PubMed ID: 29718223 [TBL] [Abstract][Full Text] [Related]
33. Detection and management of latent tuberculosis infections before biologic therapy for psoriasis. Amerio P; Amoruso G; Bardazzi F; Campanati A; Cassano N; Conti A; Gisondi P; Guarneri C; Mazzotta A; Piaserico S; Prestinari F; Prignano F; Zane C; de Simone C J Dermatolog Treat; 2013 Aug; 24(4):305-11. PubMed ID: 22208431 [TBL] [Abstract][Full Text] [Related]
34. House calls by community health workers and public health nurses to improve adherence to isoniazid monotherapy for latent tuberculosis infection: a retrospective study. Chang AH; Polesky A; Bhatia G BMC Public Health; 2013 Sep; 13():894. PubMed ID: 24073620 [TBL] [Abstract][Full Text] [Related]
36. Safety in moderate-to-severe plaque psoriasis patients with latent tuberculosis treated with guselkumab and anti-tuberculosis treatments concomitantly: results from pooled phase 3 VOYAGE 1 & VOYAGE 2 trials. Puig L; Tsai TF; Bhutani T; Uy J; Ramachandran P; Song M; You Y; Gooderham M; Lebwohl M J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1744-1749. PubMed ID: 32289190 [TBL] [Abstract][Full Text] [Related]
37. Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infection. Megna M; Patruno C; Bongiorno MR; Gambardella A; Guarneri C; Foti C; Lembo S; Loconsole F; Fabbrocini G J Dermatolog Treat; 2022 Aug; 33(5):2629-2633. PubMed ID: 35385362 [TBL] [Abstract][Full Text] [Related]
38. Latent tuberculosis infection screening prior to biological treatment in Tunisian patients. Slouma M; Mahmoud I; Saidane O; Bouden S; Abdelmoula L Therapie; 2017 Oct; 72(5):573-578. PubMed ID: 28318613 [TBL] [Abstract][Full Text] [Related]
40. Severe psoriasis entering remission after treatment for latent tuberculosis with isoniazid: Report of two cases. Partarrieu-Mejías F; Hernández-Bel P; Giácaman-von der Weth M; Pérez-Ferriols A J Dermatol; 2019 Sep; 46(9):798-801. PubMed ID: 31325342 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]